(19)

(11)

EP 4 561 566 A1

(12)

(43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23847607.1 (22) Date of filing: 28.07.2023

(51) International Patent Classification (IPC):  A61K 31/395(2006.01) A61K 31/485(2006.01) A61K 31/33(2006.01) A61K 31/445(2006.01) A61K 31/343(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/445; A61K 31/485; A61P 25/28; A61K 31/135; A61K 31/4045; A61K 31/015; A61K 31/495; A61K 31/34; A61K 31/438; A61K 31/5375; A61K 31/496 (86) International application number: PCT/US2023/071251 (87) International publication number: WO 2024/026480 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 29.07.2022 US 202263393555 P (71) Applicant: Anavex Life Sciences Corp. New York, NY 10111 (US)	(72) Inventor: MISSLING, Christopher U. New York, New York 10111 (US) (74) Representative: SONN Patentanwälte GmbH & Co KG  Riemergasse 14 1010 Wien 1010 Wien (AT)